Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)

SHA:600436 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,394	1,488	1,159	2,496	7,097	5,168
Short-Term Investments	-	3,520	9,014	6,202	-	-
Trading Asset Securities	-	-	-	-	8.8	0.01
Cash & Short-Term Investments	1,394	5,008	10,173	8,698	7,106	5,168
Cash Growth	-41.29%	-50.78%	16.95%	22.42%	37.48%	21.23%
Accounts Receivable	998.14	894.43	1,021	859.49	673.3	574.34
Other Receivables	75.44	67.88	65.15	107.94	134.95	70.11
Receivables	1,074	962.31	1,086	967.43	808.25	644.45
Inventory	4,946	4,967	3,379	2,628	2,438	2,191
Prepaid Expenses	-	12.82	14.05	4.55	20.68	-
Other Current Assets	4,765	378.99	447.9	406.61	261.36	292.18
Total Current Assets	12,179	11,329	15,100	12,705	10,633	8,296
Property, Plant & Equipment	1,688	1,508	614.62	465.62	400.14	274.96
Long-Term Investments	956.82	870.45	631.98	673.7	799.87	979.2
Other Intangible Assets	269.05	273.1	291.09	319.37	220.96	259.38
Long-Term Deferred Tax Assets	133.25	155.5	187.31	167.26	166.98	85.41
Long-Term Deferred Charges	31.78	34.05	29.99	37.65	44.19	49.42
Other Long-Term Assets	3,227	3,370	225.4	235.41	255.59	261.16
Total Assets	18,485	17,540	17,080	14,604	12,521	10,206
Accounts Payable	577.75	480.01	667.92	464.9	386.99	239.94
Accrued Expenses	116.41	485.41	685.98	345.39	342.14	139.24
Short-Term Debt	838.48	892.79	989.93	970.96	775.79	718.38
Current Portion of Long-Term Debt	41.25	6.99	1.87	-	-	-
Current Portion of Leases	-	35.81	31.86	29.21	22.75	-
Current Income Taxes Payable	258.04	59.07	142.65	72.93	108.96	77.56
Current Unearned Revenue	56.49	270.81	237.1	468.57	326.56	283.75
Other Current Liabilities	435.53	142.92	125.8	158.22	173.9	341.46
Total Current Liabilities	2,324	2,374	2,883	2,510	2,137	1,800
Long-Term Debt	59.88	58.15	35.44	-	-	-
Long-Term Leases	144.66	154.58	107.29	108.8	86.67	-
Long-Term Unearned Revenue	26.22	26.68	17.67	17.01	20.24	14.68
Long-Term Deferred Tax Liabilities	0.42	0.33	30.02	61.09	74.52	47.47
Other Long-Term Liabilities	87.02	34.1	51.35	48.54	32.88	57.09
Total Liabilities	2,642	2,701	3,160	2,780	2,384	1,949
Common Stock	603.32	603.32	603.32	603.32	603.32	603.32
Additional Paid-In Capital	1,095	1,095	1,095	1,094	1,086	1,085
Retained Earnings	13,497	12,497	11,602	9,559	7,816	5,862
Comprehensive Income & Other	68.21	76.92	76.6	74.41	200.05	311.57
Total Common Equity	15,263	14,272	13,376	11,330	9,705	7,862
Minority Interest	579.5	567.01	544.17	493.97	432.07	394.39
Shareholders' Equity	15,842	14,839	13,920	11,824	10,138	8,257
Total Liabilities & Equity	18,485	17,540	17,080	14,604	12,521	10,206
Total Debt	1,084	1,148	1,166	1,109	885.21	718.38
Net Cash (Debt)	309.9	3,859	9,007	7,589	6,220	4,450
Net Cash Growth	-71.88%	-57.15%	18.67%	22.01%	39.78%	24.77%
Net Cash Per Share	0.51	6.39	14.94	12.59	10.31	7.37
Filing Date Shares Outstanding	603.32	603.32	603.32	603.32	603.32	603.32
Total Common Shares Outstanding	603.32	603.32	603.32	603.32	603.32	603.32
Working Capital	9,855	8,955	12,217	10,195	8,496	6,496
Book Value Per Share	25.30	23.66	22.17	18.78	16.09	13.03
Tangible Book Value	14,994	13,999	13,085	11,011	9,484	7,603
Tangible Book Value Per Share	24.85	23.20	21.69	18.25	15.72	12.60
Buildings	-	1,095	400.13	331.45	332.55	331.29
Machinery	-	368.02	345.33	324.4	300.25	263.39
Construction In Progress	-	314.85	157.19	60.78	14.94	1.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.